Inscripta Overview

  • Founded
  • 2015

Founded
  • Status
  • Private

  • Employees
  • 189

Employees
  • Latest Deal Type
  • Series E

  • Latest Deal Amount
  • $150M

  • Investors
  • 21

Inscripta General Information

Description

Developer of a gene-editing technology intended to offer scalable digital genome engineering with push-button simplicity. The company's technology generates low-cost libraries of thousands of designer protein, pathway, or genome variants each with specifically defined and trackable mutations, enabling researchers to design, engineer, evaluate and track results.

Contact Information

Formerly Known As
Muse Biotechnology
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Healthcare Technology Systems
Other Industries
Other Devices and Supplies
Primary Office
  • 5500 Central Avenue
  • Suite 220
  • Boulder, CO 80301
  • United States
+1 (720) 000-0000

Inscripta Timeline

2019202020212022
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Inscripta Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC (Series E) 05-Apr-2021 $150M 00000 00.00 Completed Generating Revenue
6. Later Stage VC (Series D) 30-Nov-2020 0000 00000 00000 Completed Generating Revenue
5. Later Stage VC (Series D) 11-Nov-2019 00000 00000 00000 Completed Generating Revenue
4. Later Stage VC (Series C1) 29-Mar-2019 0000 00000 00000 Completed Generating Revenue
3. Later Stage VC (Series C) 28-Feb-2019 000.00 000.00 00000 Completed Generating Revenue
2. Early Stage VC (Series B) 16-Feb-2017 $23M $29M 000.00 Completed Generating Revenue
1. Early Stage VC (Series A) 10-May-2016 $6.04M $6.04M 0000 Completed Startup
To view Inscripta’s complete valuation and funding history, request access »

Inscripta Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series E 00,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series D 00,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series C1 00,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series C 00,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series B 19,784,629 $0.000010 6% $1.17 $1.17 1x $1.17 13.44%
Series A 5,157,970 $0.000010 6% $1.17 $1.17 1x $1.17 3.5%
To view Inscripta’s complete cap table history, request access »

Inscripta Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of a gene-editing technology intended to offer scalable digital genome engineering with push-button simplicity
Other Healthcare Technology Systems
Boulder, CO
189 As of 2022
00000
0.00 0000-00-00
00000000000 00000

000000

m, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irur
0000000000000
Medford, MA
0 As of 0000
00.000
00.00 0000-00-00
000000&0 00.000

0000 0

rcitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehen
000000000 00000 (0000000000)
Toronto, Canada
000 As of 0000
00000
00000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Inscripta Competitors (11)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
enEvolv Formerly VC-backed Medford, MA 0 00.000 000000&0 00.000
0000 00000000 Venture Capital-Backed Toronto, Canada 000 00000 00000000000 00000
00000000 Venture Capital-Backed Redwood City, CA 000 00000 00000000000 00000
0000000 Venture Capital-Backed Beijing, China 000 00000 00000000000 00000
0000000 0000000000 Formerly VC-backed Berkeley, CA 000 00000 00000000 00000
You’re viewing 5 of 11 competitors. Get the full list »

Inscripta Patents

Inscripta Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20220298502-A1 Nuclease and nickase fusion proteins for increased homologous recombination in mammalian cells Pending 17-Mar-2021 0000000000
US-20220290129-A1 Microbial cells for plastic degradation Pending 12-Mar-2021 00000000000
US-20220267812-A1 Multiplexed engineered cells and systems for biofuel production Pending 21-Feb-2021 000000000
US-20220275377-A1 Dual strand nucleic acid-guided nickase editing Pending 16-Feb-2021 00000000 0
US-11332742-B1 Mad nucleases Active 07-Jan-2021 C12N9/22 000
To view Inscripta’s complete patent history, request access »

Inscripta Executive Team (13)

Name Title Board Seat Contact Info
Ron Mcgrath Chief Financial Officer
Andrew Garst Ph.D Co-Founder
Paul Hardenbol Ph.D Vice President, Biology
Todd Rubano Vice President, Information Systems & Software
Michael Graige Ph.D Advisor
You’re viewing 5 of 13 executive team members. Get the full list »

Inscripta Board Members (8)

Name Representing Role Since
Bryan Roberts Ph.D Venrock Board Member 000 0000
Eric Moessinger Self Board Observer 000 0000
John Stuelpnagel Self Chairman 000 0000
Kristala Prather Self Board Member 000 0000
Roger Wyse Ph.D Spruce Capital Partners Board Member 000 0000
You’re viewing 5 of 8 board members. Get the full list »

Inscripta Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Inscripta Investors (21)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
D1 Capital Partners Hedge Fund Minority 000 0000 000000 0
Durable Capital Partners Growth/Expansion Minority 000 0000 000000 0
Fidelity Management & Research Venture Capital Minority 000 0000 000000 0
GoldenArc Venture Capital Minority 000 0000 000000 0
Jonathan Feldstein Angel (individual) Minority 000 0000 000000 0
You’re viewing 5 of 21 investors. Get the full list »

Inscripta Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000 000000 05-Sep-2018 0000000000 Biotechnology 00000 000
To view Inscripta’s complete acquisitions history, request access »